Management of Oxcarbazepine Drug Reactions

Immediate Assessment and Discontinuation

Assess airway, breathing, and circulation following standard resuscitation protocols, and monitor vital signs, cardiac rhythm, and neurological status continuously in patients with suspected oxcarbazepine hypersensitivity reactions 1
Establish intravenous access for medication administration in patients with suspected oxcarbazepine hypersensitivity reactions 2

Administer corticosteroids at an equivalent dose of 1-2 mg/kg of IV methylprednisolone every 6 hours for severe reactions, as recommended by the American Society of Clinical Oncology 3, 4

Administer epinephrine 0.2-0.5 mg (1 mg/mL) intramuscularly into the lateral thigh, repeat every 5-15 minutes as needed, and provide aggressive fluid resuscitation with normal saline 1-2 L IV at 5-10 mL/kg in first 5 minutes, as recommended by the American Heart Association 3, 4
Give H1/H2 antagonists: diphenhydramine 50 mg IV plus ranitidine 50 mg IV (or cimetidine 300 mg IV), and corticosteroids equivalent to 1-2 mg/kg IV methylprednisolone every 6 hours, as recommended by the American Academy of Allergy, Asthma, and Immunology 3, 4

Secure airway with bag-mask ventilation or endotracheal intubation if CNS depression with loss of protective reflexes occurs, and administer benzodiazepines (diazepam first-line or midazolam) for seizures or severe agitation, as recommended by the American Association of Poison Control Centers 2
Contact poison control (1-800-222-1222 in US) for expert guidance, and monitor ECG for intraventricular conduction delay, as recommended by the American Heart Association 2

Observe for at least 24 hours for severe reactions, and document the reaction in detail to guide future medication choices, as recommended by the American Academy of Neurology 3, 4, 5